Medlive Technology Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Medlive Technology stock has a consensus rating of "Strong Buy" and an average price target of $12.82. The average 1-year stock price forecast is 92.49% higher than the current stock price, while the lowest is $11.15 (+67.42%) and the highest is $17.18 (+157.96%).

Price Target: $12.82 (+92.49%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$11.15	$12.82	$11.59	$17.18
Change	+67.42%	+92.49%	+74.02%	+157.96%

* Price targets were last updated on Apr 13, 2026.

Analyst Ratings

The average analyst rating for Medlive Technology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	4	4	3	4	5	5
Buy	0	0	0	0	0	0
Hold	1	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	4	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Citic Securities No rating	Citic Securities	Buy Maintains $17.00	Buy	Maintains	$17.00	+155.26%	Apr 13, 2026
Unknown Analyst CICC No rating	CICC	Buy Maintains $11.40	Buy	Maintains	$11.40	+71.17%	Apr 2, 2026
Unknown Analyst Guotai Haitong No rating	Guotai Haitong	Buy Maintains $10.90	Buy	Maintains	$10.90	+63.66%	Mar 31, 2026

Financial Forecast

Revenue This Year

755.80M

from 642.16M

17.70%

from 642.16M

Revenue Next Year

887.00M

from 755.80M

17.36%

from 755.80M

EPS This Year

0.52

from 0.46

11.97%

from 0.46

EPS Next Year

0.59

from 0.52

13.94%

from 0.52

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	284.44M	314.05M	412.00M	558.46M	642.16M	755.80M
Revenue Growth	33.21%	10.41%	31.19%	35.55%	14.99%	17.70%
Gross Profit	200.73M	212.74M	251.34M	327.22M	385.44M	450.46M
Gross Margin	70.57%	67.74%	61.00%	58.59%	60.02%	59.60%
Operating Income	61.60M	59.82M	65.01M	117.44M	167.36M	249.25M
Net Income	40.62M	117.32M	242.30M	315.15M	334.34M	349.05M
EPS	-	-	-	-	0.46	0.52
EPS Growth	-	-	-	-	10.85%	11.97%
Forward PE	6.21	45.73	47.25	24.68	18.19	11.06
Dividend / Share	0.02	0.07	0.23	0.26	0.26	0.25
Dividend Growth	-	284.71%	253.98%	11.06%	1.17%	-4.18%
Free Cash Flow	64.42M	43.61M	48.96M	46.04M	62.40M	197.00M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue	2026	2027	2028
High	793.0M
Avg	755.8M
Low	733.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	23.5%
Avg	17.7%
Low	14.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.52
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	12.0%
Low	-